KRT7 and neoplasm: The mIHC analysis (Fig. 8a) enabled simultaneous detection of tumor (CK7+) and immune (NKp46, PD-1, NKG2A) markers within the same tissue section, allowing precise distinction between tumor and immune components, particularly important in metastatic lesions, where infiltrates are dense and heterogeneous.